Pegaspargase
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 310 publications
Drug-associated acute pancreatitis in paediatric versus adult reports: a disproportionality analysis using FAERS.
Journal: European journal of pediatrics
Published: May 22, 2026
Economic burden associated with switching from frontline pegaspargase or calaspargase pegol to second-line recombinant Erwinia in pediatrics and adolescents/young adults with acute lymphoblastic leukemia.
Journal: Journal of medical economics
Published: May 21, 2026
Aggressive NK-cell leukemia with CD5(+)CD10(-) monoclonal B cell lymphocytosis and hemophagocytic lymphohistiocytosis: a case report and literature review
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: May 20, 2026
Pegaspargase Rechallenge Following Grade 2 Hypersensitivity Reaction in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 16-001.
Journal: Pediatric blood & cancer
Published: March 13, 2026
Immune-Mediated IgA Nephropathy Induced by PD-1 Blockade in Extranodal NK/T-Cell Lymphoma.
Journal: International medical case reports journal
Published: January 26, 2026
Daratumumab-based salvage therapy enables umbilical cord blood transplantation in multiline refractory, elderly T-lymphoblastic lymphoma: a case report.
Journal: Frontiers in immunology
Published: November 10, 2025
Assessing the clinical and economic impact of delayed versus early pegaspargase.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: October 30, 2025
Natural Killer/T-Cell Lymphoma-Associated Hemophagocytic lymphohistiocytosis-a Rare and Dangerous Disease.
Journal: Blood and lymphatic cancer : targets and therapy
Published: October 15, 2025
Last Updated: 09/26/2026